Thromboresistant materials incorporating pyrazinone protease inhibitors as thromboresistant surfaces and for medical devices

Details for Australian Patent Application No. 2003213524 (hide)

Owner 3-Dimensional Pharmaceuticals, Inc.

Inventors Tomczuk, Bruce E; Markotan, Thomas P; Lu, Tianbao

Agent Callinan

Pub. Number AU-B-2003213524

Parent 759427

Filing date 16 July 2003

Wipo publication date 14 August 2003

Acceptance publication date 18 May 2006

International Classifications

C07K 5/078 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

31 July 2003 Complete Application Filed

14 August 2003 Application Open to Public Inspection

  Published as AU-B-2003213524

18 May 2006 Application Accepted

  Published as AU-B-2003213524

14 September 2006 Standard Patent Sealed

15 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003213525-Aerial cableway system and cableway cabin

2003213523-A machine for picking up sleepers of a track